Cancer Clinical Trial
Official title:
Quantifying and Measuring the Economic Impact of Nursing Activities During the Hospital Stay of High Complexity Oncologic Care Patients
the study consists of an observational study aimed at quantifying the economic burden of the nursing activities on the overall cost of hospitalizations funded through DRG tariffs for Major complexity oncology patients.
Study design
The methodological approach used to achieve the objective of this research is quantitative.
A mixed study design is being adopted:
1. Retrospective study to determine the nature and volume of activity provided at nursing
classes of patients whose admission is attributed to a specific DRG
2. Longitudinal prospective study to determine the variability of costs of nurses with
regard to DRG refund, comparatively to distribution of patients for every single
section (high, medium, low complexity).
Study population The sample has been chosen considering the prevalence of hospitalizations
per year in medical oncology U.O.C. related to certain DRG and characterized by greater
complexity of care, so as to provide a useful information base for study. For the
retrospective study the survey will be conducted on a sample of 150 patients. Patients will
be enrolled at high, medium and low complexity of care, hospitalized for chemotherapy and
for biliary obstructive urinary tract and in the first half of 2016. It is estimated that
the sample represents 30% of the total number of admissions made in 2016. A prospective
longitudinal study will take into consideration a sample of 150 patients with the same
characteristics considered for enrollment in the retrospective study.
The study will include patients who under go: CHT with a duration of hospital stay of 2-3
days (microcitomi and NHL), CHT with a length of hospital stay of 4-5 days (sarcomas), CHT
with a length of hospital stay > 5 days or at high doses (testicle cancer, Ewing's sarcoma
and bone sarcoma) and patients with higher complexity care.
Patients of 18 years of age or less will be excluded, as well as patients that were
transferred to other units while inpatient, patients transferred in U.O.C. of Oncology after
major surgery procedures in other departments, and admissions that are outliers.
The duration for the monitoring phase on the allocation and the distribution of patients
among the different sections of hospital care intensity (Intensità di cure, IC) and care
complexity (Complessità Assistenziale, CA), based on the results obtained by the Triage of
corridor (TriCO), is estimated for 3 months up to a maximum of six months starting from
March 2016. For the collection of data relating to the amount and types of activities
provided in the first half of 2016 is estimated to have a maximum of 30 days and others 30
days for the detection the relative DRG reimbursed for hospitalizations considered.
Survey instruments
- Professional Assessment Instrument (PAI). It is a tool that documents nursing processes
implemented in a computerized way using nursing language according to the North
American Nursing Diagnosis Association International (NANDA-I).
- Hospital discharge card (Scheda di dimissione ospedaliera, SDO). It is a tool that
contains information about each patient discharged, that are necessary for the
attribution to DRG and for finding the rate payable for each episode of hospitalization
- Scheda di mobilità interna dei pazienti. It is a card that contains data of Tri-CO at
the entrance of the patient and any variations of that index during hospitalization.
Interventions The study will be presented to the manager and coordinator of the U.O.C.
Medical Oncology through a moment of training/information.
In order to collect data on the variation of Tri-CO during hospitalization, and consequently
the different allocation to U.O.C. of Oncology of patients in sections of low, medium and
high complexity of care, a point of contact (nurse) will be identified who will deal with
the collection and retention of such information in the manner set out in the research
protocol.
Outcome measures
The primary outcome expected by the survey is the quantification of the volume of nursing
activities provided to patients and its cost. In addition, we expect to realize economic
indicators which make it possible to ascertain:
- Cost weight of the nursing staff on the DRG rate reimbursed in relation to the
complexity care of the patient;
- Cost weight of the nursing staff on the reimbursement for hospitalization in connection
with the DRG of patient discharge.
- Gap between theoretical and actual cost of nurses in relation to the care delivered for
a specific patient; Knowledge of actual costs for each distinct and specific episode of
hospitalization would enhance its "uniqueness". An economic analysis of labor nursing
costs for individual patient could provide input for the determination of the costs of
all the professionals of the Foundation, contributing to the improvement of corporate
strategic management for resource allocation.
Statistical analysis Statistical analyses will be performed using methods of descriptive
statistics and inferential statistics appropriate to the sample size and study variables.
Prospective longitudinal study will be used to determine the frequency distribution and the
variance on the stay of the patients in each individual section of hospital in-patient
treatment which is attributed to a specific DRG. Then a factorial analysis and regression
techniques will be used to measure the type of bond that exists between the dependent
variable Y (nursing) and independent variables X1, X2, X3 ... (DRG, age, days of
hospitalization, complications, etc). Then the analysis will continue by studying which
variables will affect the distribution of patients for IC and CA level and how it can change
this assignment during a single in-patient episode, creating a variability in costs of
services paid.
;
Observational Model: Cohort
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05346796 -
Survivorship Plan HEalth REcord (SPHERE) Implementation Trial
|
N/A | |
| Recruiting |
NCT05094804 -
A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents
|
Phase 1/Phase 2 | |
| Completed |
NCT04867850 -
Effect of Behavioral Nudges on Serious Illness Conversation Documentation
|
N/A | |
| Enrolling by invitation |
NCT04086251 -
Remote Electronic Patient Monitoring in Oncology Patients
|
N/A | |
| Completed |
NCT01285037 -
A Study of LY2801653 in Advanced Cancer
|
Phase 1 | |
| Completed |
NCT00680992 -
Study of Denosumab in Subjects With Giant Cell Tumor of Bone
|
Phase 2 | |
| Completed |
NCT00062842 -
Study of Irinotecan on a Weekly Schedule in Children
|
Phase 1 | |
| Active, not recruiting |
NCT04548063 -
Consent Forms in Cancer Research: Examining the Effect of Length on Readability
|
N/A | |
| Completed |
NCT04337203 -
Shared Healthcare Actions and Reflections Electronic Systems in Survivorship
|
N/A | |
| Recruiting |
NCT04349293 -
Ex-vivo Evaluation of the Reactivity of the Immune Infiltrate of Cancers to Treatments With Monoclonal Antibodies Targeting the Immunomodulatory Pathways
|
N/A | |
| Terminated |
NCT02866851 -
Feasibility Study of Monitoring by Web-application on Cytopenia Related to Chemotherapy
|
N/A | |
| Active, not recruiting |
NCT05304988 -
Development and Validation of the EFT for Adolescents With Cancer
|
||
| Completed |
NCT04448041 -
CRANE Feasibility Study: Nutritional Intervention for Patients Undergoing Cancer Surgery in Low- and Middle-Income Countries
|
||
| Completed |
NCT00340522 -
Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development
|
||
| Recruiting |
NCT04843891 -
Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis.
|
Phase 1 | |
| Active, not recruiting |
NCT03844048 -
An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial
|
Phase 3 | |
| Completed |
NCT03109041 -
Initial Feasibility Study to Treat Resectable Pancreatic Cancer With a Planar LDR Source
|
Phase 1 | |
| Completed |
NCT03167372 -
Pilot Comparison of N-of-1 Trials of Light Therapy
|
N/A | |
| Terminated |
NCT01441115 -
ECI301 and Radiation for Advanced or Metastatic Cancer
|
Phase 1 | |
| Recruiting |
NCT06206785 -
Resting Energy Expenditure in Palliative Cancer Patients
|